Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 in Acute Ischemic Stroke
NCT02362984Phase 3Terminated
- Sponsor
- Dexa Medica
- Start
- Oct 2014
- Primary completion
- Feb 2017
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS1033 in ischemic stroke, sponsored by Dexa Medica. Started Oct 2014; status: terminated.
02
Drugs
DLBS1033
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02362984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362984.